What is Acadia Pharmaceuticals's investing cash flow?

Acadia Pharmaceuticals (ACAD) reported investing cash flow of $66.28M in Q1 2026.

How has Acadia Pharmaceuticals's investing cash flow changed year-over-year?

Acadia Pharmaceuticals's investing cash flow increased by 153.4% year-over-year, from -$124.05M to $66.28M.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Acadia Pharmaceuticals ACAD Investing Cash Flow

Investing Cash Flow at other companies

BiogenBIIB

-$209.5M-343%

Neurocrine BiosciencesNBIX

-$506.2M-3,665%

Catalyst PharmaceuticalCPRX

-$27K—

PTC TherapeuticsPTCT

-$93.74M+49.2%

BridgeBio PharmaBBIO

-$42.74M-2,579%

TG TherapeuticsTGTX

-$9.86M+23.7%

Other financials

Income statement

See full

Revenue$268.1M+9.7%

Gross profit$243.3M+8.6%

Operating income-$4.6M-124%

Net income$3.6M-80.8%

EPS (diluted)$0.02-81.8%

Balance sheet

See full

Cash & equivalents$282.2M+29.6%

Total debt$50.8M-9.3%

Total equity$1.2B+63.1%

Total assets$1.6B+41.8%

Cash flow

See full

Operating cash flow$34.0M+67.2%

CapEx$5.2M—

Free cash flow$28.8M+41.6%

Valuation

See full

Market cap$3.7B+37.0%

Enterprise value$3.47B+36.6%

P/E9.9×-2.0×

P/S3.4×+0.7×

Profitability

See full

Gross margin91.5%-0.6pp

Operating margin7.4%-16.2pp

Net margin34.3%+11.3pp

FCF margin18.9%—

Returns & leverage

See full

Return on equity37.3%+0.1pp

Debt / equity0×0.0×

Current ratio3.6×+0.7×

Where this comes from

Reported directly by Acadia Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Acadia Pharmaceuticals's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's investing cash flow?: Acadia Pharmaceuticals (ACAD) reported investing cash flow of $66.28M in Q1 2026.
How has Acadia Pharmaceuticals's investing cash flow changed year-over-year?: Acadia Pharmaceuticals's investing cash flow increased by 153.4% year-over-year, from -$124.05M to $66.28M.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.